Palomino Laboratories (PALX) Cash from Operations (2023 - 2025)
Palomino Laboratories (PALX) reported Cash from Operations of 343500.0 for Q3 2025, down 1189.47% on a YoY basis from 31529.0 in Q3 2024, and down 582.29% sequentially from 50345.0 in Q2 2025.
Palomino Laboratories (PALX) Cash from Operations (2023 - 2025) Analysis & Trends
Palomino Laboratories (PALX) has 3 years of Cash from Operations data on file, last reported at 343500.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Operations fell 1189.47% year-over-year to 343500.0; the trailing twelve-month figure through Sep 2025 stood at 558260.0 (changed N/A YoY), and the FY2024 full-year result was 166637.0, down 109.93% from the prior year.
- Cash from Operations declined to 343500.0 in Q3 2025, from 50345.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 31529.0 in Q3 2024 to a low of 343500.0 in Q3 2025.
- A 3-year average of 97249.5 and a median of 53555.5 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 195.01% in 2024 and plunged 1189.47% in 2025, its largest moves.
- Tracing PALX's Cash from Operations over 3 years: stood at 56766.0 in 2023, then tumbled by 195.01% to 167467.0 in 2024, then tumbled by 105.12% to 343500.0 in 2025.
- Business Quant data shows PALX's Cash from Operations at 343500.0 in Q3 2025, 50345.0 in Q2 2025, and 3052.0 in Q1 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -343,500.00 |
| Sep 30, 2025 | -343,500.00 |
| Jun 30, 2025 | -50,345.00 |
| Jun 30, 2025 | -50,345.00 |
| Mar 31, 2025 | 3,052.00 |
| Mar 31, 2025 | 3,052.00 |
| Dec 31, 2024 | -167,467.00 |
| Dec 31, 2024 | -167,467.00 |
| Sep 30, 2024 | 31,529.00 |
| Sep 30, 2024 | 31,529.00 |
| Dec 31, 2023 | -56,766.00 |
| Dec 31, 2023 | -56,766.00 |